Products for Research Use Only

Bevacizumab

CAT: 1410-M22136-01Size: 1 EachDry Ice: NoHazardous: No
Product image 1
1 / 1
CAT#:1410-M22136-01Size:1 Each
Selected
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Quick Request Actions
Description
Ipilimumab anti-CTLA-4) is an immunomodulatory monoclonal antibody directed against the cell surface antigen CTLA-4 and also a type of immune checkpoint inhibitor.Bevacizumab a humanized monoclonal antibody specifically binds to all VEGF-A isoforms with high affinity.
CAS Number
216974-75-3
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
149 kDa
Molecular Formula
——
Notes
Research use only, not for human use.
Receptor
VEGFR

Popular Products